Prof. Dr. Tamer Atasever
Is this your profile? Claim it and verify your details.
Claim profilePerson ↔ Disease
Which diseases does this doctor work on?
-
Breast Neoplasms 6 publicationsSource: OpenAlex / PubMed MeSHView publications
- Carcinoma, Squamous Cell 3 publications
- Lung Neoplasms 3 publications
- Head and Neck Neoplasms 2 publications
- Carcinoma, Non-Small-Cell Lung 2 publications
- Graves Disease 2 publications
- Carcinoma, Ductal, Breast 2 publications
- Breast Diseases 2 publications
- Carcinoma, Small Cell 2 publications
Person ↔ Disease
Which topics does this doctor work on?
Medical areas of interest stated by the doctor on the institution profile. Source: medipol.com.tr.
- İyot Tedavisi
- Lutesyum Tedavisi
CV
Education and experience
Experience
- 2010 - 2011Gazi ÜniversitesiProf.Dr.
- 2006 - 2012Ankara Düzen LaboratuvarıNükleer Tıp Bölümünün Direktörlüğü
- 2003 - 2003Gazi ÜniversitesiProf.Dr.
- 1996 - 1996Gazi ÜniversitesiDr.Öğr.Üyesi
- 1992 - 1993Ankara Üniversitesi Tıp FakültesiUzm.Dr.
Education
- 1992Ankara Üniversitesi Tıp Fakültesi, Nükleer Tıpmedipol.com.tr
- 1984Erciyes Üniversitesi, Tıp Fakültesimedipol.com.tr
Trust
Where does this information come from?
The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.
- SpecialtyNuclear Medicinemedipol.com.trFrom source
- InstitutionMEDİPOL Acıbadem Bölge Hastanesi, Medipol Mega Üniversite Hastanesimedipol.com.trFrom source
- Area of workBreast NeoplasmsExtracted from 6 publications · Model version —From source
- Publications71 publicationsOpenAlexFrom source
- Languagesİngilizcemedipol.com.trFrom source
- Last synchronised4 November 2026 20:15https://medipol.com.tr/doktorlarimiz/profdr-tamer-atasevermedipol.com.tr
Scientific work
Publications on Breast Neoplasms
-
Real-World Outcomes of 177Lu-PSMA-617 Radioligand Therapy in Elderly Patients with Metastatic Castration-Resistant Prostate Cancer
Cerrahpasa Medical Journal, 2026
DOI 10.5152/cjm.2026.26082 Open-access full textSource: OpenAlex
-
Factors Associated with Response to 177Lu-PSMA-617 Radioligand Therapy in Metastatic Castration-Resistant Prostate Cancer: A Retrospective Analysis
Research Square, 2026
DOI 10.21203/rs.3.rs-11303324/v1 Open-access full textSource: OpenAlex
-
Real-World Outcomes Of Lu-177 PSMA In Patients With Metastatic Castration-Resistant Prostate Cancer: A Retrospective Single-Center Experience
Research Square, 2023
DOI 10.21203/rs.3.rs-3365105/v1 Open-access full textSource: OpenAlex
-
Imaging Techniques for Metastatic Thyroid Medullary Cancer
DOAJ (DOAJ: Directory of Open Access Journals), 2022
Source: OpenAlex
-
Procedure Guideline for Lymphoscintigraphy and Sentinel Lymph Node: Malignant Melanoma
Nuclear Medicine Seminars, 2020
DOI 10.4274/nts.galenos.2020.0026 Source: OpenAlex
-
F-18 FDG PET/CT Practice Guideline in Oncology
Nuclear Medicine Seminars, 2020
DOI 10.4274/nts.galenos.2020.0028 Source: OpenAlex
-
Procedur Guideline for Lymphoscintigraphy and Sentinel Lymph Node in Breast Cancer
Nuclear Medicine Seminars, 2020
DOI 10.4274/nts.galenos.2020.0027 Source: OpenAlex
-
F-18 FDG PET/CT Practice Guideline in Oncology: Assesment of Treatment Response
Nuclear Medicine Seminars, 2020
DOI 10.4274/nts.galenos.2020.0029 Source: OpenAlex
-
Intense fluoro-2-deoxyglucose uptake in high-grade prostatic adenocarcinoma with negligible prostate-specific membrane antigen expression
Urology Annals, 2019
DOI 10.4103/ua.ua_11_19 PMID 31649469 3 citations (Europe PMC) Open-access full textSource: OpenAlex
-
The value of Ga-68-PSMA PET/CT in biochemical recurrence of prostatic carcinoma (Pca)
2017
Source: OpenAlex